High-risk and selected benign breast lesions diagnosed on core needle biopsy: Evidence for and against immediate surgical excision.
Harbhajanka A, Gilmore HL, Calhoun BC.
Mod Pathol. 2022 Nov;35(11):1500-1508. doi: 10.1038/s41379-022-01092-w. Epub 2022 Jun 2.
PMID:35654997
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Elfgen C, Leo C, Kubik-Huch RA, Muenst S, Schmidt N, Quinn C, McNally S, van Diest PJ, Mann RM, Bago-Horvath Z, Bernathova M, Regitnig P, Fuchsjäger M, Schwegler-Guggemos D, Maranta M, Zehbe S, Tausch C, Güth U, Fallenberg EM, Schrading S, Kothari A, Sonnenschein M, Kampmann G, Kulka J, Tille JC, Körner M, Decker T, Lax SF, Daniaux M, Bjelic-Radisic V, Kacerovsky-Strobl S, Condorelli R, Gnant M, Varga Z.
Virchows Arch. 2023 Jul;483(1):5-20. doi: 10.1007/s00428-023-03566-x. Epub 2023 Jun 17.
PMID:37330436
Management of High-Risk Breast Lesions.
Bahl M.
Radiol Clin North Am. 2021 Jan;59(1):29-40. doi: 10.1016/j.rcl.2020.08.005.
PMID:33222998
Assessment accuracy of core needle biopsy for hormone receptors in breast cancer: a meta-analysis.
Li S, Yang X, Zhang Y, Fan L, Zhang F, Chen L, Zhou Y, Chen X, Jiang J.
Breast Cancer Res Treat. 2012 Sep;135(2):325-34. doi: 10.1007/s10549-012-2063-z. Epub 2012 Apr 22.